Enhanced expression of nuclear factor I/B in oxaliplatin‐resistant human cancer cell lines
Enhanced expression of nuclear factor I/B in oxaliplatin‐resistant human cancer cell lines
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Oxaliplatin is a third‐generation platinum drug that has favorable activity in cisplatin‐resistant cells. However, the molecular mechanisms underlying oxaliplatin resistance are not well understood. To investigate the molecular mechanisms involved, resistant cell lines were independently derived from colon cancer (DLD1) and bladder cancer (T24) cel...
Alternative Titles
Full title
Enhanced expression of nuclear factor I/B in oxaliplatin‐resistant human cancer cell lines
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_847597837
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_847597837
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/j.1349-7006.2010.01784.x
